REPORT ID 3476

Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Report 2017

Publish Date
13-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the Asia-Pacific Intravenous Immunoglobulin (IVIg) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Intravenous Immunoglobulin (IVIg) for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Intravenous Immunoglobulin (IVIg) market competition by top manufacturers/players, with Intravenous Immunoglobulin (IVIg) sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    CSL Behring
    Grifols
    Octapharma
    Shire
    ADMA Biologics
    Bayer
    Bharat Serum and Vaccines
    Biotest
    China Biologic Products
    Hualan Biological Engineering
    Kedrion Biopharma
    Sanquin

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Neurology
    Hematology
    Immunology

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Immunology
    Oncology
    Pulmonology
    Rheumatology
    Transplant
    Neurology
    Hematology
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Report 2017
1 Intravenous Immunoglobulin (IVIg) Overview
    1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
    1.2 Classification of Intravenous Immunoglobulin (IVIg) by Product Category
        1.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size (Sales) Comparison by Types (2012-2022)
        1.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Neurology
        1.2.4 Hematology
        1.2.5 Immunology
    1.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market by Application/End Users
        1.3.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales (Volume) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Immunology
        1.3.3 Oncology
        1.3.4 Pulmonology
        1.3.5 Rheumatology
        1.3.6 Transplant
        1.3.7 Neurology
        1.3.8 Hematology
        1.3.9 Others
    1.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market by Region
        1.4.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 China Status and Prospect (2012-2022)
        1.4.3 Japan Status and Prospect (2012-2022)
        1.4.4 South Korea Status and Prospect (2012-2022)
        1.4.5 Taiwan Status and Prospect (2012-2022)
        1.4.6 India Status and Prospect (2012-2022)
        1.4.7 Southeast Asia Status and Prospect (2012-2022)
        1.4.8 Australia Status and Prospect (2012-2022)
    1.5 Asia-Pacific Market Size (Value and Volume) of Intravenous Immunoglobulin (IVIg) (2012-2022)
        1.5.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Growth Rate (2012-2022)
        1.5.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2022)

2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
        2.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Share by Players/Suppliers (2012-2017)
    2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) (Volume and Value) by Type
        2.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Market Share by Type (2012-2017)
        2.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Type (2012-2017)
    2.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) (Volume) by Application
    2.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) (Volume and Value) by Region
        2.4.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales and Market Share by Region (2012-2017)
        2.4.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Market Share by Region (2012-2017)

3 China Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price)
    3.1 China Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
        3.1.1 China Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
        3.1.2 China Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
        3.1.3 China Intravenous Immunoglobulin (IVIg) Sales Price Trend (2012-2017)
    3.2 China Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Type
    3.3 China Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Application

4 Japan Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price)
    4.1 Japan Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
        4.1.1 Japan Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
        4.1.2 Japan Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
        4.1.3 Japan Intravenous Immunoglobulin (IVIg) Sales Price Trend (2012-2017)
    4.2 Japan Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Type
    4.3 Japan Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Application

5 South Korea Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price)
    5.1 South Korea Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
        5.1.1 South Korea Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
        5.1.2 South Korea Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
        5.1.3 South Korea Intravenous Immunoglobulin (IVIg) Sales Price Trend (2012-2017)
    5.2 South Korea Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Type
    5.3 South Korea Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Application

6 Taiwan Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price)
    6.1 Taiwan Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
        6.1.1 Taiwan Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
        6.1.2 Taiwan Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
        6.1.3 Taiwan Intravenous Immunoglobulin (IVIg) Sales Price Trend (2012-2017)
    6.2 Taiwan Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Type
    6.3 Taiwan Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Application

7 India Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price)
    7.1 India Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
        7.1.1 India Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
        7.1.2 India Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
        7.1.3 India Intravenous Immunoglobulin (IVIg) Sales Price Trend (2012-2017)
    7.2 India Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Type
    7.3 India Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Application

8 Southeast Asia Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price)
    8.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
        8.1.1 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
        8.1.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
        8.1.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Price Trend (2012-2017)
    8.2 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Type
    8.3 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Application

9 Australia Intravenous Immunoglobulin (IVIg) (Volume, Value and Sales Price)
    9.1 Australia Intravenous Immunoglobulin (IVIg) Sales and Value (2012-2017)
        9.1.1 Australia Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate (2012-2017)
        9.1.2 Australia Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate (2012-2017)
        9.1.3 Australia Intravenous Immunoglobulin (IVIg) Sales Price Trend (2012-2017)
    9.2 Australia Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Type
    9.3 Australia Intravenous Immunoglobulin (IVIg) Sales Volume and Market Share by Application

10 Asia-Pacific Intravenous Immunoglobulin (IVIg) Players/Suppliers Profiles and Sales Data
    10.1 CSL Behring
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 CSL Behring Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.1.4 Main Business/Business Overview
    10.2 Grifols
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.2.4 Main Business/Business Overview
    10.3 Octapharma
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.3.4 Main Business/Business Overview
    10.4 Shire
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Shire Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.4.4 Main Business/Business Overview
    10.5 ADMA Biologics
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 ADMA Biologics Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.5.4 Main Business/Business Overview
    10.6 Bayer
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Bayer Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.6.4 Main Business/Business Overview
    10.7 Bharat Serum and Vaccines
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Bharat Serum and Vaccines Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.7.4 Main Business/Business Overview
    10.8 Biotest
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.8.4 Main Business/Business Overview
    10.9 China Biologic Products
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 China Biologic Products Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.9.4 Main Business/Business Overview
    10.10 Hualan Biological Engineering
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Intravenous Immunoglobulin (IVIg) Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Hualan Biological Engineering Intravenous Immunoglobulin (IVIg) Sales, Revenue, Price and Gross Margin (2012-2017)
        10.10.4 Main Business/Business Overview
    10.11 Kedrion Biopharma
    10.12 Sanquin

11 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
    11.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Intravenous Immunoglobulin (IVIg) Major Manufacturers in 2016
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Forecast (2017-2022)
    15.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue and Price Forecast (2017-2022)
        15.1.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate Forecast (2017-2022)
        15.1.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate Forecast (2017-2022)
        15.1.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Price and Trend Forecast (2017-2022)
    15.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Volume and Growth Rate Forecast by Region (2017-2022)
        15.2.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Revenue and Growth Rate Forecast by Region (2017-2022)
        15.2.3 China Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.4 Japan Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.5 South Korea Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.6 Taiwan Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.7 India Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.8 Southeast Asia Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast (2017-2022)
        15.2.9 Australia Intravenous Immunoglobulin (IVIg) Sales, Revenue and Growth Rate Forecast (2017-2022)